55
Participants
Start Date
August 18, 2020
Primary Completion Date
June 29, 2021
Study Completion Date
June 29, 2021
TetraGraph
FDA approved neuromuscular transmission monitor capable of measuring the depth of neuromuscular block in anesthetized patients who received neuromuscular blocking agents. TetraGraph uses EMG to measure the muscle action potentials that are generated in response to electrical neurostimulation via skin electrodes.
Mayo Clinic in Florida, Jacksonville
Lead Sponsor
Mayo Clinic
OTHER